Financials Results for the Half Year Ended September 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Longlife Hospital and Research Ltd reported its H1 FY26 results (ended Sept 30, 2025) showing zero revenue from operations, down from Rs. 57.73 lakhs in the prior comparable half-year period. Total income for the period was just Rs. 0.52 lakhs, all from other income. The company swung from a net profit of Rs. 123.86 lakhs in H1 FY25 to a net loss of Rs. 132.34 lakhs in H1 FY26, translating to a loss per share of Rs. 1.26. Total expenses stood at Rs. 59.71 lakhs, primarily employee costs and other expenses, with no direct expenses. The auditor (R B Gohil & Co.) issued an unmodified limited review opinion. Cash flow from operations was negative at Rs. (44.72) lakhs, though the company still holds Rs. 2,107.97 lakhs in cash and equivalents with no outstanding borrowings.
Shareholders should be concerned by the complete absence of operating revenue in H1 FY26, suggesting either a temporary shutdown, business disruption, or transition period. While the company has a strong cash cushion (no debt, ~Rs. 21 crore in cash) to sustain operations, the path to restoring top-line growth remains unclear. This is a clear negative signal and may weigh on the stock price.